CYTK Stock: Price, Earnings History and SEC Filings
Cytokinetics, Incorporated (CYTK) last traded at $62.99, down 0.51% on the latest session and down 4.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.50 against an analyst estimate of $-1.63, a beat of 8.0%.
$62.99 -0.51%
1 month-4.43%
52-week high$88.31
52-week low$58.05
Volume1.26M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CYTK earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-1.50 | $-1.63 | +7.98% |
| Mar 2026 | May 5, 2026 | $-1.67 | $-1.67 | +0.00% |
| Dec 2025 | Feb 24, 2026 | $-1.50 | $-1.48 | -1.35% |
| Sep 2025 | Nov 5, 2025 | $-1.54 | $-1.59 | +3.14% |
CYTK beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for CYTK
SEC filing data is not available right now. You can search for CYTK on SEC EDGAR.
CYTK news
- Will Alector (ALEC) Report Negative Q3 Earnings? What You Should KnowOct 29, 2026 · finance.yahoo.com
- Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?Oct 28, 2026 · finance.yahoo.com
- Cytokinetics to Announce Third Quarter Results on November 4, 2026Oct 21, 2026 · finance.yahoo.com
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates CoverageOct 21, 2026 · finance.yahoo.com
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Oct 19, 2026 · finance.yahoo.com
- BridgeBio, Madrigal, Cytokinetics Trade Lower Ahead of Q3 Results Amid Lack of Near-Term Catalysts, BofA SaysOct 19, 2026 · finance.yahoo.com
- Can Myqorzo's Expansion and Growing Adoption Drive CYTK's Growth?Oct 19, 2026 · finance.yahoo.com
- Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic CardiomyopathyOct 19, 2026 · finance.yahoo.com
About Cytokinetics, Incorporated
Cytokinetics, Incorporated (CYTK) is a US-listed public company on Nasdaq.